Skip to main content

Hypothesis Generation: Asking the Right Question, Getting the Correct Answer

  • Chapter
  • 165 Accesses

Part of the book series: Update in Intensive Care Medicine ((UICMSOFT,volume 35))

With its state-of-the-art, often futuristic technologies, intensive care has long been touted as an example of ‘c21st century’ medicine. Yet, as we now enter that century, intensive care arguably finds itself with a reputation somewhat tarnished. For example, the pulmonary artery catheter, a mainstay in the management of the critically ill, has been recently associated with harm to intensive care unit (ICU) patients [1], Similarly, emerging data regarding mechanical ventilation practice suggests that for years we may have been harming our patients with excessive tidal volumes and ventilatory pressures [2], [3]. And although we have made considerable in-roads in our understanding of the pathophysiology of sepsis and multiple systems organ failure, our field is littered with potential therapies that failed to improve outcomes in clinical trials.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Connors AFJ, Speroff T, Dawson N V, et al (1996) The effectiveness of right heart catheterization in the initial care of critically ill patients. JAMA 276:889–897

    Article  PubMed  Google Scholar 

  2. Amato MB, Barbas C S, Medeiros D M, et al (1998) Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome. N Engl J Med 338:347–354

    Article  PubMed  CAS  Google Scholar 

  3. The NIH/NHLBI ARDS Network (1999) Low tidal ventilation is routinely used in patients with early acute lung injury. Am J Respir Crit Care Med 159:A694–A694 (Abst)

    Google Scholar 

  4. Pronovost P, Angus D C (1999) Determining the value of critical care. Clin Pulm Med 6:302–308

    Article  Google Scholar 

  5. SUPPORT Principal Investigators (1995) A controlled trial to improve care for seriously ill hospitalized patients: the study to understand prognoses and preferences for outcomes and risks of treatments. JAMA 274:1591–1598

    Article  Google Scholar 

  6. Kahn CR (1994) Picking a research problem. The critical decision. N Engl J Med 330:1530–1533

    Article  PubMed  CAS  Google Scholar 

  7. Hebert PC, Wells G, Blajchman M A, et al (1999) A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 340:409–417

    Article  PubMed  CAS  Google Scholar 

  8. Piantadosi S (1997) Clinical trials: A methodological perspective. John Wiley and Sons, New York

    Google Scholar 

  9. Sackett DL (1979) Bias in analytic research. J Chronic Dis 32:51–63

    Article  PubMed  CAS  Google Scholar 

  10. Pronovost PJ, Jencks M, Dorman T et al (1999) Organizational characteristics of intensive care units related to outcomes of abdominal aortic surgery. JAMA 281:1310–1312

    Article  PubMed  CAS  Google Scholar 

  11. Rubenfeld GD, Angus DC, Pinsky MR, et al (1999) Outcomes research in critical care: Results of the American Thoracic Society Critical Care Assembly Workshop on outcomes research. Am J Respir Crit Care Med 160:358–367

    PubMed  CAS  Google Scholar 

  12. Cook DJ, Fuller HD, Guyatt GH, et al (1994) Risk factors for gastrointestinal bleeding in critically ill patients. N Engl J Med 330:377–381

    Article  PubMed  CAS  Google Scholar 

  13. Bone RC, Balk R A, Cerra F B, et al (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 101:1644–1655

    Article  PubMed  CAS  Google Scholar 

  14. Angus DC, Kramer DJ (1993) Bacteremia and sepsis: Clinical perspectives. In: Pinsky MR, Dhainaut JF (eds) Pathophysiologic Foundations of Critical Care Medicine. Williams and Wilkins, Baltimore, pp 96–111

    Google Scholar 

  15. Bernard GR, Artigas A, Brigham KL, et al (1994) The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 149:818–824

    PubMed  CAS  Google Scholar 

  16. Knaus WA, Sun X, Nystrom O, Wagner DP (1992) Evaluation of definitions for sepsis. Chest 101:1656–1662

    Article  PubMed  CAS  Google Scholar 

  17. Rubenfeld GD, Doyle RL, Matthay MA (1995) Evaluation of definitions of ARDS. Am J Respir Crit Care Med 151:1270–1271

    PubMed  CAS  Google Scholar 

  18. Knaus WA, Harrell FE J, Fisher CJ, et al (1993) The clinical evaluation of new drugs for sepsis. A prospective study design based on survival analysis. JAMA 270:1233–1241

    Article  PubMed  CAS  Google Scholar 

  19. Marshall JC, Cook DJ, Christou NV, Bernard GR, Sprung CL, Sibbald WJ (1995) Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Crit Care Med 23:1638–1652

    Article  PubMed  CAS  Google Scholar 

  20. Vincent JL, Moreno R, Takala J, et al (1996) The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. Intensive Care Med 22:707–710

    Article  PubMed  CAS  Google Scholar 

  21. Piper RD, Cook DJ, Bone RC, Sibbald WJ (1996) Introducing critical appraisal to studies of animal models investigating novel therapies in sepsis. Crit Care Med 24:2059–2070

    Article  PubMed  CAS  Google Scholar 

  22. Vincent JL (1997) Dear SIRS, I’m sorry to say that I don’t like you. Crit Care Med 25:372–374

    Article  PubMed  CAS  Google Scholar 

  23. Rangel-Frausto MS, Pittet D, Costigan M, Hwang T, Davis CS, Wenzel RP (1995) The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA 273:117–123

    Article  PubMed  CAS  Google Scholar 

  24. Salvo I, de Cian W, Musicco M, et al (1995) The Italian SEPSIS study: preliminary results on the incidence and evolution of SIRS, sepsis, severe sepsis and septic shock. Intensive Care Med 21:S244–S249

    Article  PubMed  Google Scholar 

  25. Sands KE, Bates DW, Lanken PN, et al (1997) Epidemiology of sepsis syndrome in 8 academic medical centers. Academic Medical Center Consortium Sepsis Project Working Group. JAMA 278:234–240

    Article  PubMed  CAS  Google Scholar 

  26. Dougnac A, Angus DC, Hernandez G, et al (1996) Severe SIRS in Chile: Natural history and new organ dysfunction scores. Intensive Care Med 22 (suppl 3):321 (Abst)

    Google Scholar 

  27. Angus, D. C, Dougnac, A., Hernandez, et al (1996) Sepsis and SIRS: Are we any nearer to consensus? Intensive Care Med 22 (suppl 3):273 (Abst)

    Google Scholar 

  28. Bone RC, Grodzin CJ, Balk RA (1997) Sepsis: a new hypothesis for pathogenesis of the disease process. Chest 112:235–243

    Article  PubMed  CAS  Google Scholar 

  29. Angus DC (1998) Discourse on method: Measuring the value of new therapies in intensive care. In: Vincent JL (ed), Yearbook of Intensive Care and Emergency Medicine, Springer-Verlag, Berlin, pp 263–279

    Google Scholar 

  30. Anonymous (1997) A comparison of reteplase with alteplase for acute myocardial infarction. The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO III) Investigators. N Engl J Med 337:1118–1123

    Article  Google Scholar 

  31. Ware JH, Antman EM (1997) Equivalence trials. N Engl J Med 337:1159–1161

    Article  PubMed  CAS  Google Scholar 

  32. The GUSTO Investigators (1993) An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 329:673–682

    Article  Google Scholar 

  33. Hornberger J, Wrone E (1997) When to base clinical policies on observational versus randomized trial data. Ann Intern Med 127:697–703

    PubMed  CAS  Google Scholar 

  34. Galanos C, Freudenberg MA (1993) Mechanisms of endotoxin shock and endotoxin hypersensitivity. Immunobiology 187:346–356

    Article  PubMed  CAS  Google Scholar 

  35. Stewart TE, Meade MO, Cook DJ, et al (1998) Evaluation of a ventilation strategy to prevent barotrauma in patients at high risk for acute respiratory distress syndrome. Pressure- and Volume-Limited Ventilation Strategy Group. N Engl J Med 338:355–361

    Article  PubMed  CAS  Google Scholar 

  36. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study (1995) Endarterectomy for asymptomatic carotid artery stenosis. JAMA 273:1421–1428

    Article  Google Scholar 

  37. Tu JV, Hannan EL, Anderson GM, et al (1998) The fall and rise of carotid endarterectomy in the United States and Canada. N Engl J Med 339:1441–1447

    Article  PubMed  CAS  Google Scholar 

  38. Wennberg DE, Lucas FL, Birkmeyer JD, Bredenberg CE, Fisher ES (1998) Variation in carotid endarterectomy mortality in the Medicare population: trial hospitals, volume, and patient characteristics. JAMA 279:1278–1281

    Article  PubMed  CAS  Google Scholar 

  39. Brun-Buisson C (1994) The HA-1A saga: the scientific and ethical dilemma of innovative and costly therapies. Intensive Care Med 20:314–316

    Article  PubMed  CAS  Google Scholar 

  40. Greenman RL, Schein RM, Martin MA, et al (1991) A controlled clinical trial of E5 murine monoclonal IgM antibody to endotoxin in the treatment of gram-negative sepsis. JAMA 266:1097–1102

    Article  PubMed  CAS  Google Scholar 

  41. Ziegler EJ, Fisher CJ Jr, Sprung CL, et al (1991) Treatment of gram-negative bacteremia and septic shock with HA- 1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. N Engl J Med 324:429–436

    Article  PubMed  CAS  Google Scholar 

  42. Morris AH, Wallace CJ, Menlove RL, et al (1994) Randomized clinical trial of pressure-controlled inverse ratio ventilation and extracorporeal CO2 removal for adult respiratory distress syndrome. Am J Respir Cr it Care Med 149:295–305

    CAS  Google Scholar 

  43. Willatts SM, Radford S, Leitermann M (1995) Effect of the antiendotoxic agent, taurolidine, in the treatment of sepsis syndrome: a placebo-controlled, double-blind trial. Crit Care Med 23:1033–1039

    Article  PubMed  CAS  Google Scholar 

  44. Reinhart K, Wiegand-Lohnert C, Grimminger F, et al (1996) Assessment of the safety and efficacy of the monoclonal anti- tumor necrosis factor antibody-fragment, MAK 195F, in patients with sepsis and septic shock: a multicenter, randomized, placebo- controlled, dose-ranging study. Crit Care Med 24:733–742

    Article  PubMed  CAS  Google Scholar 

  45. Chalfin DB, Holbein ME, Fein AM, Carlon G C (1993) Cost-effectiveness of monoclonal antibodies to gram-negative endotoxin in the treatment of gram-negative sepsis in ICU patients. JAMA 269:249–254

    Article  PubMed  CAS  Google Scholar 

  46. Knaus WA, Draper E A, Wagner D P, Zimmerman J E (1985) Prognosis in acute organ-system failure. Ann Surg 202:685–693

    Article  PubMed  CAS  Google Scholar 

  47. Raffin TA (1989) Intensive care unit survival of patients with systemic illness. Am Rev Respir Dis 140:S28–S35

    PubMed  CAS  Google Scholar 

  48. 2nd European Consensus Conference in Intensive Care Medicine (1994) Predicting outcome in ICU patients. Intensive Care Med 20:390–397

    Article  Google Scholar 

  49. Weinstein MC, Stason W B (1977) Foundations of cost-effectiveness analysis for health and medical practices. N Engl J Med 296:716–721

    Article  PubMed  CAS  Google Scholar 

  50. Ridley S A, Wallace P G (1990) Quality of life after intensive care. Anaesthesia 45:808–813

    Article  PubMed  CAS  Google Scholar 

  51. Tarlov AR,Ware JE, Greenfields S, Nelson EC, Perrin E, Zubkoff M (1989) The Medical Outcomes Study. An application of methods for monitoring the results of medical care. JAMA 262:925–930

    Article  PubMed  CAS  Google Scholar 

  52. Visser MC, Fletcher AE, Parr G, Simpson A, Bulpitt CJ (1994) A comparison of three quality of life instruments in subjects with angina pectoris: the Sickness Impact Profile, the Nottingham Health Profile, and the Quality of Well Being Scale. J Clin Epidemiol 47:157–163

    Article  PubMed  CAS  Google Scholar 

  53. Kaplan RM, Atkins CJ, Timms R (1984) Validity of a quality of well-being scale as an outcome measure in chronic obstructive pulmonary disease. J Chronic Dis 37:85–95

    Article  PubMed  CAS  Google Scholar 

  54. Chelluri L, Grenvik AN, Silverman M (1995) Intensive care for critically ill elderly: mortality, costs, and quality of life. Review of the literature. Arch Intern Med 155:1013–1022

    Article  PubMed  CAS  Google Scholar 

  55. Slatyer MA, James OF, Moore PG, Leeder SR (1986) Costs, severity of illness and outcome in intensive care. Anaesth Intensive Care 14:381–389

    PubMed  CAS  Google Scholar 

  56. Freemantie N, Drummond M (1997) Should clinical trials with concurrent economic analyses be blinded? JAMA 277:63–64.

    Article  Google Scholar 

  57. Weinstein MC, Siegel JE, Gold MR, Kamlet MS, Russell LB, for the Panel on Cost-Effectiveness in Health and Medicine (1996) Recommendations of the panel on cost-effectiveness in health and medicine. JAMA 276:1253–1258

    Article  PubMed  CAS  Google Scholar 

  58. Linden PK, Angus D C, Chelluri L, Branch RA (1995) The influence of clinical study design on cost-effectiveness projections for the treatment of gram-negative sepsis with human anti-endotoxin antibody. J Crit Care 10:154–164

    Article  PubMed  CAS  Google Scholar 

  59. Russell LB, Gold MR, Siegel JE, Daniels N, Weinstein MC (1996) The role of cost-effectiveness analysis in health and medicine. Panel on Cost-Effectiveness in Health and Medicine. JAMA 276:1172–1177

    Article  PubMed  CAS  Google Scholar 

  60. Neonatal Inhaled Nitric Oxide Study Group (1997) Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure. N Engl J Med 336:597–604

    Article  Google Scholar 

  61. Roberts MS, Angus DC, Clermont G, and Linde-Zwirble W T (1997) From efficacy to effectiveness: Problems in translating the results of clinical trials into cost effectiveness analyses. Med Decis Making 117:540 (Abst)

    Google Scholar 

  62. Davidson TA, Caldwell ES, Curtis JR, Hudson LD, Steinberg KP (1999) Reduced quality of life in survivors of acute respiratory distress syndrome compared with critically ill control patients. JAMA 281:354–360

    Article  PubMed  CAS  Google Scholar 

  63. Angus DC, Pinsky MR (1997) Risk prediction: Judging the judges. Intensive Care Med 23:363–365

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Springer Science+Business Media New York

About this chapter

Cite this chapter

Angus, D.C., Pronovost, P. (2002). Hypothesis Generation: Asking the Right Question, Getting the Correct Answer. In: Sibbald, W.J., Bion, J.F. (eds) Evaluating Critical Care. Update in Intensive Care Medicine, vol 35. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-56719-3_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-56719-3_12

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-42606-6

  • Online ISBN: 978-3-642-56719-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics